MedPath

Effect of QIGUI FUYUAN decoction on rehabilitation and recurrence prevention after stroke and its mechanism of promoting nerve regeneratio

Phase 1
Conditions
Ischemic stroke
Registration Number
ITMCTR2200006366
Lead Sponsor
Department of science and technology of Hainan Province
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

? meet the above diagnostic criteria of Western medicine and TCM syndrome differentiation; ? Those aged from 18 to 80; ? The patients did not take any traditional Chinese medicine 2 weeks before enrollment; ? Normal liver and kidney function; ? Those who have not participated in other clinical drug trials recently, or have stopped taking drugs for more than half a month; ? Patients volunteered for the trial and signed informed consent.

Exclusion Criteria

? Age < 18 years old or > 80 years old; ? Patients with severe liver, lung, heart, tumor and other diseases; ? Patients with any form of intracerebral hemorrhage; ? Simple lacunar infarction or cerebral infarction caused by posterior circulation; ? Failing to take medicine as required, unable to judge the therapeutic effect, or incomplete data affect the judgment of curative effect; ? Pregnant and lactating women; ? Those who are allergic to the drugs and have mental disorders.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IHSS;ALT/AST;Recurrence rate of stroke;mRS;Barthel;
Secondary Outcome Measures
NameTimeMethod
blood pressure;GLU;Incidence of Shoulder-hand Syndrome;OX-LDL;
© Copyright 2025. All Rights Reserved by MedPath